US equities |
SPCX $174.95 ▲+2.26% NVDA $242.54 ▲+1.52% MU $1,065.65 ▲+0.16% MRVL $291.00 ▲+7.28% AMD $649.84 ▲+2.86% SNDK $1,669.01 ▼-2.06% AVGO $377.27 ▲+4.07% TSLA $380.65 ▲+0.51%
FinancialContent

Latest News about NRXS

Recent news which mentions NRXS

Earnings Scheduled For May 12, 2026
Tickers ABOS ACCS ACHV AEYE
Tags DCO OGI SPWR
From Benzinga
Earnings Scheduled For August 12, 2025
Tickers ABOS ABSI ACCS ACXP
Tags LAZR PRTS VG
From Benzinga
Earnings Outlook For Neuraxis
Tickers NRXS
Tags NRXS Earnings BZI/EP
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers BRNS CRL CYCC DHAI
Tags CRL CYCC NRXS
From Benzinga
NeurAxis Stock Soars on Groundbreaking FDA Clearance for Pediatric Treatment
Tickers NEWS NRXS
Tags Stocks NRXS 33
From Wall Street Pit
Gold Gains Over 1%; Amer Sports Posts Upbeat Earnings
Tickers AS EKSO IHS NEWS
Tags Earnings Trading Ideas TRML
From Benzinga
Nasdaq Falls 100 Points; Home Depot Sales Top Views
Tickers BLMZ EKSO HD MULN
Tags SYTA Equities HD
From Benzinga
Earnings Scheduled For May 12, 2025
Tickers ACHC ACHR ACNT ADV
Tags PSNY AQST LAND
From Benzinga
Earnings Scheduled For March 20, 2025
Tickers ACN ADAP ALAR AMPX
Tags CBUS BRAG SNWV
From Benzinga
Earnings Scheduled For November 12, 2024
Tickers ABOS ABSI ACNT ACTG
Tags AMPS BLFS SOUN
From Benzinga
NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024
Tickers NRXS
Tags Earnings Reports Market News NRXS
From InvestorPlace
NRXS Stock Earnings: Neuraxis Reported Results for Q1 2024
Tickers NRXS
Tags NYSEMKT:NRXS NRXS Earnings Reports
From InvestorPlace
NRXS Stock Earnings: Neuraxis Misses Revenue for Q4 2023
Tickers NRXS
Tags Earnings Reports Market News NRXS
From InvestorPlace
Earnings Scheduled For April 9, 2024
Tickers AEHR CGNT GREE KITT
Tags NEOG Earnings TLRY
From Benzinga
Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Tickers ACB AGIL AMPH ASTI
Tags GDEV LAW NVOS
From Benzinga
EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome
Tickers NRXS
Tags Market News Health Care General
From Benzinga
EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids
Tickers NRXS
Tags NRXS General Briefs
From Benzinga